Format

Send to

Choose Destination
See comment in PubMed Commons below
Vaccine. 2014 Mar 20;32(14):1527-35. doi: 10.1016/j.vaccine.2013.07.087. Epub 2014 Feb 25.

Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines.

Author information

1
Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland. Electronic address: gottliebs@who.int.
2
Department of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
3
Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
4
Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Abstract

An estimated 499 million curable sexually transmitted infections (STIs; gonorrhea, chlamydia, syphilis, and trichomoniasis) occurred globally in 2008. In addition, well over 500 million people are estimated to have a viral STI such as herpes simplex virus type 2 (HSV-2) or human papillomavirus (HPV) at any point in time. STIs result in a large global burden of sexual, reproductive, and maternal-child health consequences, including genital symptoms, pregnancy complications, cancer, infertility, and enhanced HIV transmission, as well as important psychosocial consequences and financial costs. STI control strategies based primarily on behavioral primary prevention and STI case management have had clear successes, but gains have not been universal. Current STI control is hampered or threatened by several behavioral, biological, and implementation challenges, including a large proportion of asymptomatic infections, lack of feasible diagnostic tests globally, antimicrobial resistance, repeat infections, and barriers to intervention access, availability, and scale-up. Vaccines against HPV and hepatitis B virus offer a new paradigm for STI control. Challenges to existing STI prevention efforts provide important reasons for working toward additional STI vaccines. We summarize the global epidemiology of STIs and STI-associated complications, examine challenges to existing STI prevention efforts, and discuss the need for new STI vaccines for future prevention efforts.

KEYWORDS:

Prevention and control; Sexually transmitted diseases; Vaccines

PMID:
24581979
DOI:
10.1016/j.vaccine.2013.07.087
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center